MAPK8 and endothelial dysfunction: A previous study found that anagliptin, a dipeptidyl peptidase IV (DPP-4) inhibitor, suppresses IH by preventing endothelial dysfunction and regulating SOD-1/RhoA/Jun N-terminal kinase- (JNK-) mediated EC migration following balloon-induced injury [31].